Literature DB >> 15912561

Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.

P Kovács1, G Csaba.   

Abstract

Structural changes of microtubules, incorporation of radioactively labelled components into phospholipids, cell motility, growth and phagocytosis were studied under the effect of four drugs affecting microtubular assembly: colchicine, nocodazole, vinblastine and taxol. Although the first three agents influence microtubules in the direction of depolymerization and the fourth stabilizes them, their effects on the structure of microtubules cannot be explained by this. Using confocal microscopy after an acetylated anti-tubulin label, in nocodazole- and colchicine-treated cells, the basal body cages disappear and longitudinal microtubules (LM) became thinner without changing transversal microtubules (TM). After taxol treatment LM also became thinner, however TM disappeared. Under the effect of vinblastine TM became thinner, without influencing LM. These drugs influence the incorporation of components ([(3)H]-serine, [(3)H]-palmitic acid and (32)P) into phospholipids, however their effect is equivocal and cannot be consequently coupled with the effect on the microtubules. Nocodazole, vinblastine and taxol significantly reduced the cell's motility, however colchicine did so to a lesser degree. Vinblastine and nocodazole totally inhibited, and taxol significantly decreased cell growth, while colchicine in a lower concentration increased the multiplication of cells. Phagocytosis was not significantly influenced after 1 min, but after 5 min all the agents studied (except colchicine) significantly inhibited phagocytosis. After 15 and 30 min each molecule caused highly significant inhibition. The experiments demonstrate that drugs affecting microtubular assembly dynamics influence differently the diverse (longitudinal, transversal etc.) microtubular systems of Tetrahymena and also differently influence microtubule-dependent physiological processes. The latter are more dependent on microtubular dynamics than are changes in phospholipid signalling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15912561     DOI: 10.1002/cbf.1238

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  6 in total

1.  Microtubule plus-end conformations and dynamics in the periphery of interphase mouse fibroblasts.

Authors:  Sandra Zovko; Jan Pieter Abrahams; Abraham J Koster; Niels Galjart; A Mieke Mommaas
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

Review 2.  Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.

Authors:  V Dostál; L Libusová
Journal:  Protoplasma       Date:  2014-03-21       Impact factor: 3.356

Review 3.  Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation.

Authors:  A D Garg; E Romano; N Rufo; P Agostinis
Journal:  Cell Death Differ       Date:  2016-02-19       Impact factor: 15.828

4.  Anticolchicine cytotoxicity enhanced by Dan Gua-Fang, a Chinese herb prescription in ECV304 in mediums.

Authors:  Xian-Pei Heng; Ke-Ji Chen; Zhen-Feng Hong; Wei-Dong He; Ke-Dan Chu; Wen-Lie Chen; Hai-Xia Zheng; Liu-Qing Yang; Ling Chen; Fang Guo
Journal:  Chin J Integr Med       Date:  2011-03-09       Impact factor: 1.978

5.  A novel synthetic analog of 5, 8-disubstituted quinazolines blocks mitosis and induces apoptosis of tumor cells by inhibiting microtubule polymerization.

Authors:  Wei Tian; Lili Qin; Qiaoling Song; Li He; Midan Ai; Yi Jin; Zuyu Zhou; Song You; Yaqiu Long; Qiang Yu
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

6.  A simple microscopy assay to teach the processes of phagocytosis and exocytosis.

Authors:  Ross Gray; Andrew Gray; Jessica L Fite; Renée Jordan; Sarah Stark; Kari Naylor
Journal:  CBE Life Sci Educ       Date:  2012       Impact factor: 3.325

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.